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RNA-binding proteins are known to play an important role in a number of aspects of development, although in most cases
the precise mechanism of action remains unknown. We have previously described the isolation of an RNA-binding protein,
hermes, that is expressed at very high levels in the differentiating myocardium. Here, we report experiments aimed at
elucidating the functional role of hermes in development. Utilizing the Xenopus oocyte, we show that hermes is localized
primarily to the cytoplasm, can associate in a multiprotein complex, and is able to bind to mature RNA transcripts in vivo.
Overexpression of hermes in the developing embryo dramatically and specifically inhibits heart development. In particular,
transcripts encoding the myocardial differentiation markers, cardiac troponin I and cardiac -actin, are absent, and overall
morphological development of the heart is eliminated. Examination of markers of precardiac tissue showed that expression
of GATA-4 is normal, while the levels of Nkx2–5 mRNA are strongly reduced. Overall, these studies suggest that hermes
plays a role in the regulation of mature transcripts required for myocardial differentiation. To our knowledge, this is the first
evidence for an RNA-binding protein playing a direct role in regulation of vertebrate heart development. © 2002 Elsevier
Science (USA)
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The majority of molecular studies of early heart develop-
ment have focused on the identification and characteriza-
tion of growth factors and transcription factors expressed in
the cardiogenic region and in the heart. At the very earliest
stages of heart development, BMP signaling and localized
inhibition of Wnt signaling are required for a subset of
mesodermal cells to become specified to a cardiac fate
(reviewed in Olson, 2001). Coincident with these early
signaling events, transcription factors crucial for cardiac
specification and differentiation are expressed. These in-
clude members of the tinman, GATA, MEF2, and Hand
gene families (reviewed in Bodmer and Venkatesh, 1998;
Evans, 1999; Harvey et al., 1999).
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4 To whom correspondence should be addressed. Fax: (520) 626-Given the complex series of events involved in organo-
genesis and cellular differentiation, it seems likely that
posttranscriptional mechanisms will also be employed to
fine tune the broader programs regulated by growth and
transcription factors. Indeed, a body of evidence indicates
that numerous different developmental processes are regu-
lated at the level of RNA splicing, stability, localization, or
translation. One of the best characterized examples occurs
during axis formation in Drosophila, where localization of
specific RNA transcripts and translational regulation of
their expression is essential for correct A/P axis formation
(Grunert and St. Johnson, 1996; Curtis, 1994). Furthermore,
differentiation of neurons in the Drosophila embryo is
dependent on the correct splicing and translation of mes-
sages, mediated by the RNA-binding protein, elav
(Koushika et al., 1996; Antic and Keene, 1997; Antic et al.,
1999; Perron et al., 1999). Although they are not generally
as well characterized, a number of RNA-binding proteins
are also known to be involved in vertebrate development.
For example, DAZ and SpnR are required during mamma-
lian sperm development (Hauberman et al., 1998; Schuma-
cher et al., 1998), Quaking is essential for myelinization of
central nervous system neurons in the mouse (Ebersole et
al., 1996) and for notochord formation in Xenopus (Zorn2097. E-mail: pkrieg@email.arizona.edu.
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and Krieg, 1997), and hnRNP-H plays a role during visceral
myogenesis (Liu et al., 2001). In addition, defects in expres-
sion of the FMR1 protein are responsible for fragile-X
syndrome in humans (Kaufmann and Reiss, 1999)
Based on the presence of recognizable sequence motifs,
hundreds of other RNA-binding proteins have been identi-
fied in vertebrates. While their precise functions remain
largely unknown, it is likely that a large proportion are
involved in posttranscriptional regulation of gene expres-
sion. One of the largest and best-characterized families of
RNA-binding proteins is the RNA Recognition Motif
(RRM) family. Members of the RRM family contain one or
more copies of a structurally conserved 80- to 100-amino-
acid domain, which includes two regions of 6–8 highly
conserved residues called RNP1 and RNP2. The RNP1 and
RNP2 domains are involved with direct contact of RNA and
are required for RNA binding (Nagai et al., 1990; Hoffman
et al., 1991). RRM proteins appear to be involved in all
aspects of RNA metabolism and are thought to mediate
their interactions through sequence-specific rather than
promiscuous binding to RNA (Burd and Dreyfuss, 1994).
RRM family sequences with a known developmental role
include sex lethal (Bell et al., 1988), elav (Robinow et al.,
1988), and squid (Kelley et al., 1997).
We have previously described the isolation of the RRM
family protein, hermes, which is prominently expressed in
the differentiating myocardium of the heart (Gerber et al.,
1999). Expression is also observed in the developing kidney
and the ganglion layer of the retina. In each of these tissues,
hermes expression is first detected at about the same time
that markers of terminal differentiation are expressed (Ger-
ber et al., 1999). In this study, we describe experiments
aimed at identifying the function of hermes during verte-
brate development. First, we have utilized the Xenopus
oocyte for experiments to determine subcellular localiza-
tion of the hermes protein and to analyze protein–protein
and protein–RNA interactions. Second, we demonstrate
that temporal misexpression of hermes in the embryo
completely eliminates myocardial differentiation and mor-
phogenesis. Furthermore, misexpression in kidney primor-
dia eliminates transcription of kidney markers. Although
the mechanism remains unknown, our studies suggest that
hermes regulates an aspect of mRNA metabolism necessary
for cardiac and kidney differentiation.
MATERIALS AND METHODS
Oocyte Injections
Oocytes were manually defolliculated and then injected with
250 ng of in vitro transcribed mRNA. Capped mRNA was synthe-
sized in vitro by using linearized hermes plasmid templates and the
Message Machine in vitro transcription kit (Ambion). Oocytes
were incubated at 18°C in OR2 (82.5 mM NaCl, 2.5 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 5 mM Hepes, pH 7.8) for
16–24 h then homogenized (25 l/oocyte) in oocyte homogeniza-
tion buffer (100 mM NaCl, 10 mM Tris–HCl, pH 7.6, 5 mM EDTA,
0.25% NP-40, 0.5 mM PMSF, and 1 mM DTT). Extracts were
centrifuged for 4 min at 14,000g to remove yolk and pigment. For
labeling of proteins, [35S]methionine (NEN) was coinjected with the
mRNA. For subcellular localization studies, the nucleus was
manually removed and individually homogenized in 25 l homog-
enization buffer.
Immunoprecipitation
Oocyte extracts equivalent to one-fifth of a single oocyte were
incubated with 2 l anti-HA polyclonal antibody (BAbCo) or 2 l
anti-myc 9E10 (Developmental Studies Hybridoma Bank, Univer-
sity of Iowa) and 40 l protein-A agarose resin in 200 l IP buffer
(100 mM NaCl, 10 mM Tris–HCl, pH 7.5, 1 mM EDTA, 0.25%
IGEPAL CA-630/NP-40), overnight at 4°C with gentle mixing.
After precipitation, pellets were washed five times in ice-cold IP
buffer. Pellets were then resuspended in SDS–PAGE loading buffer
and fractionated on an SDS–PAGE gel containing 15% acrylamide.
Immunocytochemistry
Sections of MTHermes-injected oocytes were incubated in
blocking buffer (1 PBS, 1% heat-treated lamb serum, 5% BSA) for
1 h at room temperature. The slides were incubated in a 1:200
dilution of anti-myc 9E10 monoclonal antibody (DSHB, University
of Iowa) overnight at 4°C. Slides were washed three times in 1
PBS and then incubated for 2 h at room temperature, in the dark, in
a 1:75 dilution of goat anti-mouse-FITC (Jackson Labs). Slides were
again washed three times in 1 PBS and mounted in 100 nM
Tris–HCl, pH 7.6, 80% glycerol, 1% n-propylgallate.
RNase protection
Total RNA was isolated from Xenopus embryos by homogeni-
zation in 4 M guanidinium thiocyanate, 25 mM sodium citrate,
0.5% sarkosyl, and 0.1 M -mercaptoethanol, and the homogenate
was phenol:chloroform extracted and then isopropanol precipi-
tated. After resuspension in equal volumes of TE and 8 M LiCl, the
RNA was recovered by centrifugation and then stored as an ethanol
precipitate at 20°C. For RNase protection analysis, hermes tran-
scripts were detected with a 32P- labeled antisense probe consisting
of sequences spanning nucleotides 459–773. Probe for XMax2 was
prepared as described previously (Tonissen and Krieg, 1994).
Embryo Injections
Xenopus laevis embryos were generated by using standard tech-
niques and staged according to Nieuwkoop and Faber (1994).
Capped mRNAs were synthesized in vitro by using the Message
Machine in vitro transcription kit (Ambion) and EcoRI-linearized
pT7TS-hermes and NotI-linearized CS2 vector (Turner and Wein-
traub, 1994) containing the green fluorescent protein (GFP)-coding
region. Synthetic mRNAs encoding hermes and GFP were injected
into one or both C1/C2 blastomeres to target the cardiac region, or
into the C3 blastomere to target the pronephric region, of eight-cell
embryos by using a Nanoject variable automatic injector (Drum-
mond). In the standard protocol, 250 pg of hermes mRNA was
injected with 250 pg of GFP mRNA as a lineage tracer in 4.6 nl of
water. Injected embryos were cultured at 13°C in 4% Ficoll/0.4
MMR for 12 h and then in 0.2MMR until stage 28, by which time
heart differentiation has commenced.
Loss-of-function experiments were attempted by using antisense
morpholino oligonucleotides (Gene Tools LLC). A combination of
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two antisense oligonucleotides, AS1 (5-CCGTGTCTGACTTGA-
TGCCGCTCAT-3) and AS2, (5-GTACAAGCCAGACTCCTC-
GGTGGGC-3) were used. These oligonucleotides are complemen-
tary to sequences overlapping the start site of translation and
immediately upstream of the initiation ATG, respectively, and
were designed to individually target both pseudoallelic copies of
the hermes transcript. Each oligonucleotide was demonstrated to
block translation of its respective target transcript when assayed in
the reticulocyte lysate cell-free system. To target the heart region,
a mixture of 8 ng of each morpholino oligonucleotide was injected
into both C1/C2 blastomeres at the eight-cell stage by using the
protocol described above. This represents a total of 32 ng of
oligonucleotide per embryo. A control oligonucleotide RS1 (5-
TACTCGCCGTAGTTCAGTCTGTGCC-3) representing the re-
verse of the first sequence above, and the standard control morpho-
lino provided by Gene Tools were also injected at a final amount of
32 ng per embryo.
Poly(A) Binding Assay
Oocyte extracts were prepared as described above, except that
the homogenization buffer contained 8% glycerol, 50 mM NaCl, 2
mM MgCl2, 5 mM BME, and 10 mM Tris–HCl, pH 7.6. After the
initial centrifugation of the extracts, NaCl concentration was
adjusted to 250 mM. The equivalent of 15 oocytes of extract was
passed three times over a 0.3-ml (50 mg) oligo(dT) cellulose column
(NE Biolabs) and then washed in five volumes of binding buffer (250
mM NaCl, 2 mM MgCl2, 10 mM Tris–HCl, pH 7.6). Bound material
was then eluted with 1.5 ml of 60% formamide. The eluate was
precipitated with 3 volumes of ice-cold acetone and analyzed by
SDS–PAGE.
Whole-Mount in Situ Hybridization
Digoxigenin-labeled RNA probes were prepared by using a ME-
GAscript kit (Ambion). Whole-mount in situ hybridization was
carried out as previously described (Gerber et al., 1999) and
developed by using NBT-BCIP (Roche). Paraffin sections on em-
bryos assayed by in situ hybridization were carried out by dehy-
drating the embryos in a graded ethanol series and washing twice
for 20 min each in xylene and then three times in paraplast at 60°C
for a total of 2 h. Embryos were then embedded in paraplast and
sectioned at a thickness of 10 m. Slides were dewaxed in xylene
and viewed by DIC optics. When analyzing the phenotypes of
injected embryos, statistical significance was determined by using
the Student’s t test with two-tailed, two sample unequal variance.
RESULTS
High Levels of hermes Transcript Are Present in
the Xenopus Egg
Our original study used whole-mount in situ hybridiza-
tion to determine the zygotic expression pattern of hermes
(Gerber et al., 1999). Using this protocol, hermes expression
is first detected at stages 26–28, in the developing heart and
kidney. However, when we further examined the hermes
expression profile using RNase protection analysis, we
found that hermes transcripts are also present at very high
levels in the egg (Fig. 1). During cleavage and early devel-
opment, this maternal stockpile of transcript declines sig-
nificantly, but large amounts of maternal hermes RNA
remain present through gastrulation (stage 10.5) and neu-
rula stages (stage 16). By whole-mount in situ hybridization,
tissue-specific expression of hermes becomes very clearly
visible in the heart and kidney primordia between stages 26
and 28. In the RNase protection profile in Fig. 1, no
significant increase in embryonic hermes transcript level is
obvious at stage 26, but becomes evident by the tadpole
stage (stage 36). Expression levels increase slightly through-
out later development, consistent with the in situ hybrid-
ization results, but zygotic levels remain much lower than
those observed in the egg. At present, it is not clear why the
maternal hermes transcripts were not detected in our pre-
vious in situ hybridization studies, which showed a very
clear, tissue-restricted expression pattern (Gerber et al.,
1999). It is possible, however, that broadly distributed
hermes transcripts would be much less prominent than the
same sequence expressed at high levels in a specific tissue.
Subcellular Localization in Oocytes
We have used two experimental methods to determine
the subcellular localization of the hermes protein. Both
experiments utilize the Xenopus oocyte, where the hermes
transcript is normally expressed at high levels (Fig. 1). In the
first approach, stage VI oocytes were coinjected with syn-
thetic mRNA encoding wild-type hermes and with [35S]me-
thionine, to facilitate labeling of newly translated proteins.
FIG. 1. Developmental expression of hermes. Total RNA was
extracted from staged X. laevis embryos and analyzed by RNase
protection. The equivalent of five embryos of total RNA was used
for each sample. Embryonic stage is indicated at the top of the
figure (Nieuwkoop and Faber, 1994). The position of the protected
hermes and Max fragments, with the approximate nucleotide
length in parentheses, is indicated on the left, and size markers are
on the right. The Max sequence, which is expressed at constant
levels throughout early development (Tonissen and Krieg, 1994), is
used as a loading control.
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After allowing radiolabeled protein to accumulate in the
oocyte, the germinal vesicle (GV) was manually isolated
and the cytoplasmic and GV fractions were analyzed by
SDS–PAGE. As shown in Fig. 2A, hermes protein is present
in both the nuclear and the cytoplasmic fractions. Quanti-
tation of 10 individual oocytes shows that approximately
15% of hermes is present in the nucleus and 85% is
cytoplasmic (SE  3%). In control experiments, the nuclear
protein Max is 95% nuclear and 5% cytoplasmic, whereas
the cytoplasmic protein EF-1 is 100% localized to the
cytoplasm (Fig. 2A). The very clear partitioning observed for
the EF-1 control indicates that the hermes protein de-
tected in the nuclear fraction does not result from contami-
nation of the GV sample with cytoplasmic material
In the second experiment, mature oocytes were injected
with a synthetic mRNA encoding hermes protein carrying a
myc-epitope tag or a control transcript encoding the myc-
tag alone (see Fig. 3A). Subcellular localization of hermes
protein was then visualized by immunofluorescence using
an anti-myc antibody. The results of this assay also indicate
that hermes protein is located in both the nucleus and the
cytoplasm. In the nucleus and in the animal pole region,
hermes protein appears to be evenly distributed, with no
discernible localization to nuclear or cytoplasmic subre-
gions (data not shown). However, in the vegetal region of
the oocyte, the myc-tagged hermes protein appears to be
associated with distinct granular structures (Fig. 2B). In
contrast, oocytes injected with mRNA coding for the myc-
epitope tag do not show granular staining in the vegetal
cytoplasm (Fig. 2C). This punctate staining of Myc-tagged
hermes protein in the vegetal region was observed in 11 of
14 oocytes examined, but was never observed in oocytes
expressing the Myc-epitope tag alone (0 of 12 oocytes
examined). We have also used immunofluorescence to
examine localization of Myc-epitope-tagged hermes protein
in the developing embryo until the tailbud stage. In these
experiments, the majority of hermes protein was always
observed in the cytoplasm, although a punctate pattern was
not observed (data not shown). This suggests that no major
change in the subcellular localization of hermes protein
occurs during early embryogenesis.
Association of hermes Protein with Poly(A) RNA
in Vivo
In view of our results showing that hermes protein is
localized predominantly to the cytoplasm (Fig. 2A), we
wished to determine whether hermes could associate with
poly(A) RNA in vivo. To test this possibility, oocytes were
injected with mRNA encoding different regions of the
hermes protein, each carrying a myc-epitope tag (Fig. 3A).
These constructions encode the full-length hermes protein,
the RRM domain, or the C-terminal region. As a control, all
oocytes were coinjected with mRNA encoding green fluo-
rescent protein (GFP) which is not expected to exhibit any
association with RNA within the cell. After allowing la-
beled hermes protein to accumulate, total oocyte extracts
were prepared and then passed over an oligo(dT) cellulose
column to determine whether hermes associates with
poly(A) RNA in the oocyte. The results of this experiment
are presented in Figs. 3B and 3C. As shown in Fig. 3B,
hermes is greatly enriched relative to the oocyte protein
background and to the GFP control protein. Note that the
labeled oocyte proteins in the oligo(dT)-bound fraction do
not generally correspond to the labeled bands in the loaded
material, suggesting that protein association with the col-
umn material is specific and not merely background bind-
FIG. 2. Subcellular localization of hermes in the oocyte. (A) Hermes
is present in both the nuclear and cytoplasmic compartments. Syn-
thetic mRNAs encoding either hermes, the cytoplasmic protein
EF-1, or the nuclear protein Max were injected into the cytoplasm of
Xenopus oocytes, together with [35S]methionine. Oocytes were manu-
ally dissected into cytoplasmic (C) and nuclear (N) fractions. Protein
extracts equivalent to one-fifth of each fraction from a single oocyte
were resolved on SDS–PAGE and visualized by fluorography. Results
indicate that the control proteins EF-1 and Max localize to the
cytoplasmic and nuclear fractions, respectively. hermes is present
primarily in the cytoplasm, but a small portion of hermes is found in
the nuclear fraction. (B, C) Immunolocalization of epitope-tagged
hermes protein in the oocyte. Synthetic mRNAs encoding myc-
epitope-tagged proteins were injected into mature oocytes, and the
resulting proteins were visualized by immunocytochemistry on sec-
tioned oocytes. (B) View of the vegetal region of a MTHermes-injected
oocyte. Staining appears as a punctate pattern. (C) View of the vegetal
region of an oocyte expressing myc-epitope tag alone. Staining is
diffuse and does not show the punctate pattern seen with MThermes.
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ing. Quantitation of three different experiments shows that
hermes is approximately 10-fold enriched in the poly(A)
fraction relative to GFP. When deletion constructions of
hermes are tested, only the full-length hermes protein
associates with poly(A) RNA (Fig. 3C). Neither the RRM
domain (MTRRM) or the C-terminal portion (MTCTerm) of
the hermes protein associates significantly, suggesting that
both domains are necessary for interaction with mature
mRNA. In separate experiments, we have attempted to
determine whether hermes protein translated in a reticulo-
cyte lysate can associate with RNA. Numerous experi-
ments using different target RNA populations and different
binding conditions failed to show any association of hermes
protein with RNA in vitro. Possible explanations for this
observation will be discussed later.
Protein–Protein Interactions
Many RNA-binding proteins, particularly those contain-
ing a single RNA-binding motif, function as homodimers or
homo-oligomers (Zorn and Krieg, 1997; Wang et al., 1999;
reviewed in Siomi and Dreyfuss, 1997). In order to deter-
mine whether hermes is capable of homodimerization in
vivo, we carried out coimmunoprecipitation experiments
using Xenopus oocyte extracts. Mature oocytes were in-
jected with synthetic mRNAs encoding HA-epitope tagged
and untagged versions of hermes (Fig. 3A) together with
[35S]methionine. Oocyte extracts were prepared and immu-
noprecipitation was carried out by using anti-HA antibody.
These experiments show that wild-type hermes protein
coprecipitates with HA-tagged hermes (Fig. 4A), suggesting
that hermes forms dimers or multimers in the oocyte.
However, since hermes is an RNA-binding protein, this
coimmunoprecipitation result is not necessarily straight-
forward to interpret. Indeed, the observed coimmunopre-
cipitation of hermes proteins is consistent, both with direct
protein–protein interactions, and also with a situation
where hermes protein is binding in multiple monomeric
units along a single RNA molecule. To test this latter
possibility, oocyte extracts were treated with RNase prior
to immunoprecipitation. As shown in Fig. 4A, RNase
treatment reduces but does not completely eliminate copre-
cipitation. Quantitation of this effect over five different
experiments shows that immunoprecipitation of untagged
hermes is reduced to approximately one-quarter of normal
levels by RNase treatment (27%, SE  4%). The hermes
protein association remaining after RNase treatment may
be because a small proportion of the hermes protein is
involved in direct protein/protein interactions, or because
other bound proteins protect the RNA molecule from
further RNase degradation. Nevertheless, we conclude from
these experiments that the interaction of hermes proteins
seen in immunoprecipitation experiments is at least partly
dependent on RNA. In order to determine which portions of
the hermes protein participate in this interaction, we in-
jected oocytes with mRNA encoding either the RRM
(MTRRM) or the C-terminal (MTCTerm) portions of
hermes together with untagged wild-type hermes. The
results of the immunoprecipitation experiments show that
neither of these subdomains is sufficient for stable interac-
tions with untagged hermes, either directly or through
indirect associations with RNA (Fig. 4B). This result is
consistent with the oligo(dT)-binding experiments, which
showed that full-length hermes protein is required for
association with poly(A) RNA (Fig. 3B).
Misexpression of hermes in the Embryo
Compromises Heart Differentiation
During Xenopus development, one of the earliest regions
showing tissue-restricted expression of hermes is the em-
FIG. 3. Hermes associates with poly(A) RNA in vivo. (A) Diagram
depicting different hermes constructions used for protein and RNA
interaction experiments. A 6xMyc epitope tag or a hemagglutinin
(HA) tag was fused to the full-length hermes-coding region contained
in T7TS. The myc epitope tag was also fused to subdomains of the
hermes protein, containing either the first 100 amino acids (RRM),
which includes the entire RNA-binding domain, or the last 97 amino
acids (CTerm), which includes the highly conserved C-terminal end of
the protein. (B, C) hermes associates preferentially with poly(A) in
vivo. (B) Extracts from oocytes injected with mRNA for GFP (a
nonspecific control) and wtHermes and incubated with [35S]methi-
onine (L) were passaged over an oligo(dT) cellulose column. The
bound fraction (OdT) is enriched for hermes protein relative to GFP,
indicating an ability of hermes to associate with poly(A) RNA. (C)
Repeat of the experiment in (B), except oocytes were injected with
combinations of mRNA for MThermes (as a positive control) and
mRNA for MTRRM (lanes 1 and 2) or MTCTerm (lanes 3 and 4) in
order to determine which domains of the protein are necessary for the
poly(A) interaction. Only the MTHermes is enriched in the bound
fraction, indicating that both the RRM and CTerm are necessary for
association with poly(A) RNA.
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bryonic heart. Heart expression of hermes is first detected
between stages 26 and 28, which corresponds to the time of
heart differentiation, as assayed by expression of cardiac
muscle markers such as cardiac -actin and cardiac tropo-
nin I (Hemmati-Brivanlou et al., 1990; Drysdale et al.,
1994). This correlation suggests that hermes may play a role
in regulation of transcripts involved in cardiac differentia-
tion. To investigate a possible function for hermes during
heart development, we have used microinjection to tempo-
rally misexpress hermes in the Xenopus embryo. We have
principally focused on development of the heart, rather
than other tissues, due to the availability of a number of
well-characterized pre- and postdifferentiation cardiac
markers. In initial experiments, 250 pg of hermes mRNA,
together with mRNA encoding GFP lineage tracer was
injected into a C1/C2 blastomere, in order to concentrate
hermes expression in the future heart-forming region (Dale
and Slack, 1987; Moody, 1987). Embryos injected with 250
pg of hermes mRNA appeared generally normal through all
stages of early development, indicating that the presence of
excess hermes protein does not cause nonspecific toxic
effects on embryogenesis. At stage 28/29, embryos showing
the presence of GFP lineage tracer in the heart were
analyzed for expression of myocardial markers by whole-
mount in situ hybridization. Initial analyses were carried
out by using the heart differentiation marker, cardiac
troponin I (TnIc), which is specifically expressed in cardiac
muscle (Drysdale et al., 1994). As summarized in Table 1,
expression of TnIc was greatly reduced or absent on the
injected side of 46% of all embryos analyzed (P  0.005). As
a control, we injected mRNA encoding RNP1, a mutated
form of hermes that lacks seven amino acids from the
highly conserved RNP1 of the RRM. Previous studies
indicate that mutations of the RNP1 region effectively
eliminate sequence-specific RNA binding (Heinrichs and
Baker, 1997). Our results indicate that expression of RNP1
in the heart region of the embryo has no statistically
significant effect on TnIc expression (Table 1). This obser-
vation implies that sequence-specific binding is essential
for the hermes overexpression phenotype.
In order to obtain additional information on the specific-
ity of the hermes misexpression phenotype, a more exten-
sive series of assays were carried out by using probe for
cardiac -actin, which is expressed in both cardiac and
somitic muscle (Mohun et al., 1988). When the C1/C2
blastomeres are injected, embryos with lineage tracer in the
heart region always contain tracer in the anterior somites
on the injected side, because these blastomeres contribute
to both lineages (Dale and Slack, 1987; Moody, 1987). Use of
cardiac -actin probe, therefore, permits analysis of the
effects of hermes overexpression on both heart and somite
muscle development. Results of these experiments are
presented in Fig. 5. As expected, embryos injected with GFP
alone show normal morphology and bilaterally symmetri-
cal expression of cardiac -actin in the developing heart
FIG. 4. Hermes protein–protein interactions. (A) Immunoprecipi-
tation experiment showing that the ability of hermes proteins to
complex in vivo is RNase-sensitive. Lanes 1 and 2, extracts from
oocytes injected with mRNA for untagged, wild-type hermes.
Lanes 3 and 4, extracts from oocytes injected with mRNA for only
HA-tagged hermes. Lanes 5–8, extracts from oocytes injected with
mRNA for both HA-tagged and untagged, wild-type hermes. Lanes
5–8 show that coimmunoprecipitation of hermes proteins is sen-
sitive to RNase. (B) Immunoprecipitation experiments showing
that both the RRM and C-terminal region are required for the
coimmunoprecipitation of hermes. Lanes 1–3, extracts from oo-
cytes injected with mRNA for MTHermes and wtHermes. Lanes 5
and 6, extracts from oocytes injected with mRNA for MTRRM and
wtHermes. Lanes 7–9, extracts from oocytes injected with mRNA
for MTCTerm and wtHermes. Lane marked “L” contains 20% of
total material used in the immunoprecipitation reaction. IP, im-
munoprecipitation with anti-HA or anti-myc antibody. RNase,
treatment of extracts with RNase prior to immunoprecipitation.
Lane marked “ø” is immunoprecipitation without antibody.
TABLE 1
Asymmetry of Expression of cardiac troponin I in hermes
Injected Embryos
Injected construct Total (n) % Asymmetry
Hermes  GFP 216 46%
GFP 147 5%
MTRNP1  GFP 33 3%
Note. 250 pg of hermes mRNA construct, together with 250 pg of
mRNA encoding GFP lineage tracer was injected into the future
heart-forming region of the embryo at the 4–8-cell stage and
assayed at stage 28/29. Only embryos expressing GFP tracer in the
heart region were included in this assay. Embryos were scored
positive for asymmetry if cardiac troponin expression was absent or
nearly absent on the injected side of the embryo. 250 pg of
MTRNP1, injected as a control, represents a mutated form of
hermes that eliminates RNA sequence specific binding.
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FIG. 5. Overexpression of hermes inhibits heart and kidney development. Embryos injected with mRNA encoding hermes and lineage tracer
GFP, or GFP alone. All embryos are at stage 28/29, unless otherwise specified. Whole-mount in situ hybridizations are photographed as lateral
views except for (C), (F), and (I), which are ventral views of the same embryos pictured laterally. (A–C) GFP-injected control embryos showing
normal expression of cardiac -actin in the somites (A, B) and paired heart primordia (C). (D–F) Single-sided injections cause the ablation of the
heart-forming region on the injected side (arrow) as assayed by cardiac -actin. (G–I) Double-sided injections showing complete ablation of both
heart primordia, while somite morphology (G, H) is unperturbed as assayed by cardiac -actin. (J, K) Transverse sections through stage 32
embryos (linear heart tube stage) injected with GFP mRNA only (J) or bilaterally injected with hermes mRNA (K) and assayed by cardiac -actin.
Note the absence of any cardiac -actin staining as well as the absence of a morphologically detectable heart tube in (K), although the heart tube
is easily detectable in (J). (L, M) GATA-4 expression in control embryos (L) is indistinguishable from hermes-injected embryos (M). (N, O) By
contrast, a hermes-injected embryo (O) has reduced Nkx2–5 expression compared with a control GFP-injected embryo (N). (P, Q) A stage 25
hermes-injected embryo assayed with the kidney marker X-pax2. The uninjected side (P) shows normal kidney expression, while the injected side
(Q) shows the absence of all kidney expression.
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region (Figs. 5A–5C). Embryos overexpressing hermes show
generally normal overall morphology, except for a slightly
bulbous appearance. In situ analysis reveals that embryos
overexpressing hermes show a dramatic reduction in car-
diac -actin expression in the developing heart region (Figs.
5D–5F). Importantly, cardiac -actin expression in the
somites is normal on both the injected and the uninjected
sides of the embryo, indicating that the presence of hermes
is not influencing development of somitic muscle markers.
As shown in Figs. 5G–5I, bilateral injection of 250 pg of
hermes mRNA into both the C1 and C2 blastomeres
completely eliminated cardiac -actin expression in both
heart patches. Total absence of marker expression was
observed in 30% of injected embryos (9/30), and marked
reduction in one of the heart patches was observed in an
additional 53% of the embryos (16/30). When compared
with controls, these differences are highly statistically
significant (P  0.005). In order to examine the effects of
hermes misexpression on heart morphology, bilaterally
injected embryos were allowed to develop until stage 32,
when the heart normally forms a simple linear tube (Mohun
et al., 2000; Kolker et al., 2000). Histological sections show
that embryos lacking expression of cardiac -actin in the
precardiac region also fail to form a morphologically distin-
guishable heart tube (see Figs. 5J and 5K).
The experiments so far have focused on heart muscle
differentiation markers, but it is possible that hermes
misexpression interferes with the normal expression of
regulatory molecules expressed prior to cardiac differentia-
tion. To test this possibility, hermes-overexpressing em-
bryos were assayed with probes for the cardiac regulatory
genes Nkx2–5 and GATA-4. Analysis of these embryos
showed that GATA-4 expression was largely unaltered in
tailbud stage embryos expressing hermes mRNA. Only
15% (7/45) of double side-injected embryos showed a de-
tectable reduction in GATA-4 expression in the precardiac
region, which is not significantly different when compared
to controls. This is much less than the 83% reduction or
elimination observed when the same batch of embryos was
assayed for cardiac -actin expression. In contrast, however,
analysis of tailbud embryos from the same batch shows that
Nkx2–5 expression is strongly reduced in 53% (26/57) of
hermes-overexpressing embryos (compare Fig. 5N with 5O),
which is significantly different than control embryos (P 
0.005). Overall, these experiments suggest that misexpres-
sion of hermes may be blocking expression of cardiac
differentiation markers by interfering with an upstream
regulator of cardiac development, possibly Nkx2–5.
In addition to expression in developing heart tissue,
hermes is also strongly expressed in the developing kidney.
We have carried out a preliminary series of experiments to
determine whether misexpression of hermes might also
interfere with kidney development. In these experiments,
250 pg of hermes was injected into a C3 blastomere that is
fated to contribute to pronephros and somite (Dale and
Slack, 1987). Since there are few established markers for
kidney differentiation, our assays were carried out by using
the predifferentiation marker Xpax-2, which is expressed at
high levels throughout developing kidney tissues (Heller
and Bra¨ndli, 1997; Carroll et al., 1999). As shown in Figs. 5P
and 5Q, misexpression of hermes causes a severe reduction
or ablation of Xpax-2 expression. This was observed in 36%
of injected embryos (9/26), which is statistically different
from the 5% of GFP control injected embryos (1/19) (P 
0.01). To confirm that hermes expression is not producing
nonspecific toxic effects, a proportion of the same batch of
embryos was assayed with cardiac -actin probe to exam-
ine somite development. In all cases, somite appearance on
the injected side of the embryo was indistinguishable from
that on the uninjected side (data not shown). This result is
particularly relevant because the developing kidney and the
somites are in immediate proximity to each other. We
conclude from these preliminary studies that misexpres-
sion of hermes interferes with kidney development while
leaving muscle gene expression in the somites, and overall
somite morphology, unaffected.
Morpholino Oligonucleotide Experiments
In addition to assaying for the effects of overexpression of
hermes, we attempted loss/reduction-of-function studies
using morpholino antisense oligonucleotides directed
against the hermes transcripts. A total of 32 ng of oligonu-
cleotide was targeted to the heart-forming region of the
embryo, and assays for heart gene expression and overall
heart morphology were carried out at stage 35, using in situ
hybridization with cardiac probes followed by histological
sectioning. The overall appearance of the oligonucleotide-
injected embryos was indistinguishable from uninjected
controls, suggesting that the presence of morpholino oligo-
nucleotides was not producing general toxic effects. Prior to
fixation for in situ hybridization, however, we noted that a
proportion of the hearts in antisense morpholino-injected
embryos were not beating or were beating slowly. More-
over, in situ hybridization analysis with the general muscle
marker, tropomyosin, revealed morphological defects, in-
cluding failure of the heart tube to loop correctly and
disruption of the myocardial tissue layer (data not shown).
Unexpected results, however, were obtained from embryos
injected with control morpholino oligonucleotides. Al-
though the control sequence provided by Gene Tools pro-
duced no detectable phenotype, the reverse sequence con-
trol, RS1, generated heart phenotypes indistinguishable
from those produced with the antisense hermes morpholino
oligonucleotides, namely absence of heartbeat and morpho-
logical defects in the heart tube. We conclude, therefore,
that the phenotype produced by the hermes antisense
oligonucleotides is artifactual. These results serve as a
warning that morpholino oligonucleotides may disrupt
heart formation, even when the overall development of the
embryo appears normal. The mechanism responsible for
these defects is currently unknown.
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DISCUSSION
Hermes Is Present in Both the Cytoplasm and the
Nucleus
To learn more about the possible function of hermes, we
have determined the subcellular localization of the hermes
protein. Using the oocyte as a model system, we have
shown that hermes is primarily cytoplasmic, although a
small proportion of the total protein (approximately 15%) is
routinely detected in the nucleus. While the proportion of
the total hermes protein in the nucleus is small, it is
significantly greater than would be expected if hermes
protein was freely diffusible, since the volume of the oocyte
nucleus only represents about 3% of the volume of the
entire cell. In addition, immunofluorescence studies show
that cytoplasmic hermes is concentrated in granular struc-
tures, which are especially conspicuous near the vegetal
cortex (Fig. 2B). These punctate structures are never ob-
served in control oocytes. The appearance of these struc-
tures in the oocyte is similar to that previously reported for
Vera, a protein associated with Vg1 mRNA (Deshler et al.,
1997), or for the cortical localized rough endoplasmic re-
ticulum (RER), as revealed by an antibody directed against
TRAP (Hartmann et al., 1993). These observations are
consistent with a role for hermes in translational regulation
of cortically localized messages in the oocyte.
Previous studies have shown that other RNA-binding
proteins are also present in both the nucleus and cytoplasm.
These include elav, an RRM-family protein required for
neuronal differentiation (Perron et al., 1997, 1999), boule, a
Drosophila DAZL-related protein (Cheng et al., 1998), the
human poly(A)-binding protein 1 (Afonina et al., 1998),
FMR1, the protein involved in human fragile-X syndrome
(Tamanini et al., 1999), and SEB-4, an RRM-family protein
expressed in Xenopus muscle tissue (Fetka et al., 2000).
Furthermore, it has been demonstrated that RNA-binding
proteins can exhibit different functions in different cellular
compartments. One prominent example is sex lethal,
which regulates splicing in the nucleus, but is involved in
translational repression in the cytoplasm (Bell et al., 1988;
Bashaw and Baker, 1997; Kelley et al., 1997). Although we
cannot rule out a role for hermes in the nucleus (e.g.,
splicing regulation), the fact that most hermes protein is
located in the cytoplasm suggests a role in regulating
mature mRNA, perhaps by regulating translation or mes-
sage stability. This possibility is further supported by the
observation that hermes protein is preferentially associated
with poly(A) RNA in vivo (Fig. 3B). The discovery that
hermes is expressed at high levels in the oocyte (Fig. 1) is
certainly consistent with hermes playing a role in regula-
tion of transcript stability, since the oocyte contains a very
large number of stored, stable mRNAs (Stebbins-Boaz and
Richter, 1997; Mowry and Cote, 1999)
Homodimerization of hermes Is RNA-Dependent
Previous studies have shown that RNA-binding proteins
often need to assemble into multiprotein complexes in
order to bind RNA efficiently (Nelson and Green, 1989;
Ruskin et al., 1988; Siomi and Dreyfuss, 1997). These
associations can be homodimers, heterodimers, or multi-
meric complexes. Our immunoprecipitation experiments
indicate that multiple copies of the hermes protein are
associated with each other within the cell (Fig. 4). The fact
that the association of hermes proteins is sensitive to
RNase suggests that it is not a simple protein/protein
interaction. One possible explanation is that multiple cop-
ies of hermes protein may be binding to a single RNA
molecule. In this case, there need be no physical interaction
between individual hermes proteins. The second possibility
is that RNA association is required for a conformational
change in the hermes protein. This conformational change
may allow association of hermes with other proteins
(homo-oligomerization or hetero-oligomerization). Many
RNA-binding proteins contain multiple RNA-binding mod-
ules (sometimes of different classes), and these multiple
domains are important for efficient interaction with the
target RNA (Burd and Dreyfuss, 1994). Since hermes con-
tains only a single RNA-binding domain, it is plausible that
hermes, like some other RNA-binding proteins, requires a
cofactor in order to bind RNA efficiently. For example, U2
snRNP cannot bind to its target RNA unless the necessary
cofactor, U2AF, is present (Nelson and Green, 1989; Ruskin
et al., 1988). The possibility that a protein cofactor is
required for hermes to bind RNA efficiently may explain
why neither protein–protein interactions nor protein–RNA
interactions are observed by using hermes protein that has
been translated in vitro. On the other hand, the necessary
cofactor proteins are quite likely to be present in the oocyte,
where hermes is normally expressed.
Misexpression of hermes Reveals a Role in Cardiac
Differentiation
To determine a possible role for hermes during cardiac
development, we have carried out experiments in which
hermes is expressed at both an earlier time and higher levels
than in normal development. These experiments demon-
strate that embryos overexpressing hermes show greatly
reduced expression of myocardial differentiation markers,
including TnIc and cardiac -actin (Fig. 5). Parallel experi-
ments also showed a strong downregulation of the kidney
predifferentiation marker, Xpax-2. The fact that somite
development is normal in these embryos shows that
hermes overexpression is interfering with development of
specific tissues rather than causing general toxic effects. An
important clue to the possible role of hermes during cardiac
development comes from examination of expression of
precardiac markers, such as Nkx2–5 and GATA-4. These
experiments indicate that expression of the early cardio-
genic marker, Nkx2–5, is significantly reduced in response
to hermes overexpression, whereas the levels of transcript-
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encoding GATA-4 are unaffected (Fig. 5; and Table 1). This
result is important because it shows that hermes overex-
pression is not inhibiting cardiac development nonspecifi-
cally, but is reducing the expression of a subset of genes
required for normal cardiogenesis. Since Nkx2–5 is an
important regulator of numerous cardiac regulatory factors
and differentiation (Lyons et al., 1995; Tanaka et al., 1999),
it is plausible that the absence of cardiac marker expression
in hermes-overexpressing embryos is caused by the down-
regulation of Nkx2–5 expression. It is important to note,
however, that the reduction in Nkx2–5 transcript levels
could be achieved by many different mechanisms, and we
have no evidence suggesting that Nkx2–5 transcripts are a
direct target of hermes binding.
In the Xenopus embryo, cardiac expression of hermes is
first detected at the same time that heart differentiation
markers are initially expressed (Gerber et al., 1999). It is
possible that the normal function of hermes is to modulate
the transition from the precardiac to the cardiac differenti-
ated state, perhaps by altering the expression of other
regulatory molecules. This is consistent with our observa-
tion that hermes expression downregulated Nkx2–5 in the
tailbud embryo. The observation that hermes misexpres-
sion alters heart and kidney development while leaving
somitic muscle development unchanged might be ex-
plained, either by the presence of specific accessory proteins
in the cardiac and kidney tissue, or perhaps by sequence-
specific binding. In the latter case, specific RNA targets of
hermes binding may not be present in somitic tissue.
Answers to these questions will probably depend on iden-
tification of the specific transcripts that are bound and
regulated by the hermes protein. In summary, although the
targets of hermes regulation are currently unknown, the
observation that hermes overexpression leads to loss of
expression of heart markers suggests that hermes functions
in an essential pathway during cardiac development.
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